Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
J Korean Soc Transplant. 2014 Dec;28(4):195-199. Korean. Clinical Trial. https://doi.org/10.4285/jkstn.2014.28.4.195
Kim YJ , Kim SI .
Division of Infectious Disease, Department of Internal Medicine, Seoul St. Mary's Hospital, School of Medicine, The Catholic University of Korea, Seoul, Korea. drksi@catholic.ac.kr
Abstract

Transplant candidates and recipients are at increased risk for infections, many of which are preventable by immunization. Patients who are waiting for transplant or post-transplant patients, as well as their household members and healthcare workers have completed the recommended vaccinations before transplantation. Live attenuated vaccines including varicella and MMR are generally not recommended after transplantation, thus protective level of antibodies should be detected before transplantation. Currently, pneumococcal vaccine and zoster vaccines are in clinical trial among post-transplant patients. In this article, we reviewed the guidelines for vaccination in solid organ transplant candidates and recipients and summarize the available literature on the efficacy and safety of vaccines for patients who are scheduled for or who have undergone organ transplantation.

Copyright © 2019. Korean Association of Medical Journal Editors.